Showing results (11-20 of 2,811) with videos related to

Sort By:
Pageof 282
Diabetes Technology & Therapeutics|May 27, 2021
Youth with Type 1 Diabetes Had Improvement in Continuous Glucose Monitoring Metrics During the COVID-19 PandemicFatema S Abdulhussein, Hannah Chesser, W John Boscardin, et al.
Diabetes Technology & Therapeutics|June 23, 2021
Continuous Glucose Monitoring (CGM) Is a Tool, Not a Reward: Unjustified Insurance Coverage Criteria Limit Access to CGMDavida F Kruger, John E Anderson
Diabetes Technology & Therapeutics|December 28, 2022
The Relationship Between Percent Time <70 mg/dL and Percent Time <54 mg/dL Measured by Continuous Glucose MonitoringRoy W Beck, Dan Raghinaru, Peter Calhoun, et al.
Diabetes Technology & Therapeutics|June 2, 2022
Impact of Different Types of Data Loss on Optimal Continuous Glucose Monitoring Sampling DurationHalis Kaan Akturk, Pau Herrero, Nick Oliver, et al.
Diabetes Technology & Therapeutics|June 17, 2022
Essential Continuous Glucose Monitoring Metrics: The Principal Dimensions of Glycemic Control in DiabetesEslam Montaser, Chiara Fabris, Boris Kovatchev
Diabetes Technology & Therapeutics|October 14, 2021
Associations Between Device-Measured Physical Activity and Glycemic Control and Variability Indices Under Free-Living ConditionsDouae El Fatouhi, Harris Héritier, Chloé Allémann, et al.
Diabetes Technology & Therapeutics|October 1, 2010
Health literacy, diabetes self-care, and glycemic control in adults with type 2 diabetesChandra Y Osborn, Sujeev S Bains, Leonard E Egede
Diabetes Technology & Therapeutics|August 7, 2010
The prevalence of self-monitoring of blood glucose and costs of glucometer strips in a nationwide cohortReidun L S Kjome, Anne G Granas, Kari Nerhus, et al.
Pageof 282